About PrecisionLife | Precision medicine for complex, chronic diseases

Skip to content

Our mission

Finding better, more personalized treatment & diagnostic options for people with unmet medical needs

Complex, chronic diseases are difficult to diagnose, expensive to manage, and often lack effective treatments. They represent the biggest challenge to health - affecting billions of patients and accounting for over 80% of global healthcare spending.

New proactive and preventative healthcare approaches are required to accurately identify people who are at-risk and intervene effectively to reduce the global burden of chronic diseases.

We bring the benefits of precision medicine affordably into routine clinical practice and R&D for these most common and costly diseases.

Predicting, preventing, diagnosing & treating disease to improve patient outcomes.

This is PrecisionLife.

A snapshot of our progress

Linking patients to effective treatments by the mechanism of their disease

Improving global health

>5 Billion patients lives

PrecisionLife disease studies create precision medicine opportunities in diseases with a prevalence of 5.4B people.

Proprietary disease insights

100K+ protectable trade secrets

We've created the world's largest repository of chronic disease insights & IP, including biomarkers, risk models, and novel targets.

Predictive disease models

10x signal from 10% of the data

We've generated world-leading insights into the previously unknown mechanisms driving over 60 complex diseases.

Rapid reduction to practice

Reducing health costs

Our mechanostic tests identify disease risk for early personalized intervention and prevention of major chronic diseases.

2.ALZHEIMERS-min

Enabling a new era of precision medicine

Chronic diseases are caused by a complex interplay of multiple genes and heterogeneous factors. Their complexity means that patients with the same diagnosis may have different drivers of disease and will benefit from different therapies.

These differences cannot be understood by traditional genomic analyses such as GWAS, polygenic risk scores, generative AI, or panel-based diagnostics.

Therefore, while oncology has been transformed by precision medicine, more prevalent, expensive and complex diseases have seen little benefit.

Until now...

Putting people at the center of their health

We've completely reimagined how to analyze patient data.

Using our Combinatorial Analytics & AI platform we are the first researchers to understand and stratify complex disease biology - identifying the mechanistic drivers of disease in individual patients.

This allows us to create more personalized diagnostic tools, treatment options and clinical pathways, and to find the right patients for clinical trials and new medicines based on their personal biology.

Improving probabilities of success for clinical trials, treatments and patients.

iStock-1432338987-min